Table 3.
Participants’ adherence to and knowledge of LS screening recommendations and perceived lifetime cancer risks
| Screening test | Non-adherent % (n) | Adherent % (n)
|
|
|---|---|---|---|
| Through research | Through routine care | ||
| Endometrial biopsya | 48 (32) | 42 (28)** | 10 (7)** |
| Transvaginal ultrasoundb | 49 (33) | 31 (21)* | 21 (14)* |
| Colonoscopyc | 24 (13) | 26 (14)* | 51 (28)* |
| Screening recommendations (n=74) | Correct % (n) | ||
|
| |||
| Age range to begin gynecologic screening | 61 (45) | ||
| Recommended screening frequency for: | 81 (60) | ||
| Endometrial cancer | |||
| Ovarian cancer | 74 (55) | ||
| Colorectal cancer | 82 (61) | ||
|
| |||
| Perceived lifetime cancer risks (n=74) | |||
| Under-estimation % (n) | Over-estimation % (n) | Accurate estimation % (n) | |
|
| |||
| Endometrial cancerd | 8 (6) | 30 (22) | 53 (39) |
| Ovarian cancerd | 3 (2) | 89 (66) | 7 (5) |
| Colorectal cancerd | 19 (14) | 20 (15) | 61 (45) |
a
n=67; excludes women who had a hysterectomy (with or without oophorectomy).
b
n=68; excludes women who had an oophorectomy (with or without hysterectomy).
c
n=55; excludes women with a prior CRC diagnosis.
d
Assessment of correct lifetime cancer risk estimates were based on the data provided during the genetic counseling session (3).
*
p>0.05 (χ2 =16.15, p<0.0001).
**
p>0.0001.